Press release

15 December 2021

Cellular Goods PLC

("Cellular Goods" or "the Company")

Annual General Meeting update

Further to the announcement of 6 December and in the light of recent developments concerning the Omicron variant of Covid, Cellular Goods (LSE: CBX) is making changes to the format of its Annual General Meeting ("AGM") to be held at 12 noon on 7 January 2022.

In accordance with the UK Government's guidelines on social distancing and the Government's request that people work from home wherever possible, shareholders are requested not to attend the AGM in person.  Entry to the AGM will only be permitted to those with evidence of double vaccinations and a booster injection, as well as proof of a negative lateral flow test taken within 24 hours of entry.

The Directors of the Company will not be attending in person and no presentations are planned.  Shareholders are encouraged to vote by proxy.

The Company will take questions from shareholders submitted in advance of the AGM via the following link: https://cbx.nz/AGM. Responses will be posted on the Company's website www.cellulargoods.co on 7 January 2022.

For further information please contact:

About Cellular Goods PLC:

Cellular Goods is a UK-based provider of premium consumer products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid products. The initial focus is on three product verticals: premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange.